Radical hysterectomy for FIGO stage I-IIB adenocarcinoma of the uterine cervix

被引:73
作者
Kasamatsu, T. [1 ]
Onda, T.
Sawada, M.
Kato, T.
Ikeda, S.
Sasajima, Y. [2 ]
Tsuda, H. [2 ]
机构
[1] Natl Canc Ctr, Div Gynecol, Chuo Ku, Tokyo 1040045, Japan
[2] Natl Canc Ctr, Div Diagnost Pathol, Tokyo 1040045, Japan
关键词
radical hysterectomy; adenocarcinoma; uterine cervix; FIGO stage I-IIB; SQUAMOUS-CELL CARCINOMA; PROGNOSTIC-FACTORS; HISTOLOGY; CANCER;
D O I
10.1038/sj.bjc.6605048
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
A retrospective analysis was carried out to identify risk factors for survival and relapse in patients with FIGO stage I-IIB cervical adenocarcinoma (AC), who underwent radical hysterectomy, and to compare outcome and spread pattern with those of squamous cell carcinoma (SCC). One hundred and twenty-three FIGO stage I-IIB patients with AC and 455 patients with SCC, who all underwent primary radical hysterectomy, were reviewed. Among the patients with AC, Cox model identified tumour size (95% CI: 1.35-30.71) and node metastasis (95% CI: 5.09-53.44) as independent prognostic factors for survival, and infiltration to vagina (95% CI: 1.15-5.76) and node metastasis (95% CI: 6.39-58.87) as independent prognostic factors for relapse. No significant difference was found in survival or relapse between the AC and SCC groups, after adjusting for other clinicopathological characteristics using Cox model. No significant difference was found in the positive rates of lymph nodes or location of initial failure sites between the two groups, but ovarian metastatic rate was significantly higher in patients with pathologicstage IIB AC (P = 0.02). Positive node is a common independent prognostic factor for survival and relapse of patients with AC. FIGO stage I-IIB patients with AC or SCC, who underwent radical hysterectomy, have similar prognosis and spread pattern, but different ovarian metastasis rates.
引用
收藏
页码:1400 / 1405
页数:6
相关论文
共 24 条
[1]  
Alfsen GC, 2001, CANCER, V92, P2471, DOI 10.1002/1097-0142(20011101)92:9<2471::AID-CNCR1597>3.0.CO
[2]  
2-K
[3]   Carcinoma of the cervix uteri [J].
Benedet, JL ;
Odicino, F ;
Maisonneuve, P ;
Beller, U ;
Creasman, WT ;
Heintz, APM ;
Ngan, HYS ;
Pecorelli, S .
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2003, 83 :41-78
[4]   RADIATION-THERAPY FOR ADENOCARCINOMA OF THE UTERINE CERVIX - DOES THE HISTOLOGY MATTER [J].
BEREK, JS .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1995, 32 (05) :1543-1544
[5]   COMPARISON OF THE PATTERN OF METASTATIC SPREAD OF SQUAMOUS-CELL CANCER AND ADENOCARCINOMA OF THE UTERINE CERVIX [J].
DRESCHER, CW ;
HOPKINS, MP ;
ROBERTS, JA .
GYNECOLOGIC ONCOLOGY, 1989, 33 (03) :340-343
[6]  
EIFEL PJ, 1990, CANCER-AM CANCER SOC, V65, P2507, DOI 10.1002/1097-0142(19900601)65:11<2507::AID-CNCR2820651120>3.0.CO
[7]  
2-9
[8]   ADENOCARCINOMA AS AN INDEPENDENT RISK FACTOR FOR DISEASE RECURRENCE IN PATIENTS WITH STAGE IB CERVICAL-CARCINOMA [J].
EIFEL, PJ ;
BURKE, TW ;
MORRIS, M ;
SMITH, TL .
GYNECOLOGIC ONCOLOGY, 1995, 59 (01) :38-44
[9]   Comparison of biological behavior between early-stage adenocarcinoma and squamous cell carcinoma of the uterine cervix [J].
Fregnani, Jose H. T. G. ;
Soares, Fernando A. ;
Novik, Pablo R. ;
Lopes, Ademar ;
Latorre, Maria R. D. O. .
EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2008, 136 (02) :215-223
[10]  
Grisaru D, 2001, CANCER, V92, P2999, DOI 10.1002/1097-0142(20011215)92:12<2999::AID-CNCR10145>3.0.CO